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A thought-provoking study in this issue of The EMBO
Journal shows that the circadian clock in mouse ﬁbro-
blasts is surprisingly insensitive to the inhibition of total
cellular mRNA production. The authors go on to show
intriguing parallels between compensation of period to
changes in temperature and global transcription rate.
The continual progression between day and night has applied a
constant selective pressure upon organisms to anticipate, and
entrain to, periodic changes in their environment. Cells and organ-
isms have thus evolved endogenous daily timekeeping mechanisms
that facilitate the temporal organisation of metabolic, physiological
and behavioural processes, for example, the sleep/wake cycle
(Gachon et al, 2004). These circadian (meaning ‘about daily’)
rhythms are observed in all eukaryotes, with as much as 20% of
cellular gene expression being under circadian control in mammals
(Reddy et al, 2006).
The molecular basis of cellular rhythmicity has been described as
comprising several interlinked transcriptional/translational feed-
back loops whereby clock genes, directly or indirectly, repress
their own transcription (Figure 1). In mammals, rhythmically
expressed clock genes, such as Period (PER) (1 and 2),
Cryptochrome (CRY) (1 and 2) and Bmal1, are essential for accurate
time-keeping, as mice lacking them exhibit altered period, or are
arrhythmic, at both the behavioural and cellular level (Liu et al,
2007). Therefore, in current models, the timing and amplitude of
clock gene expression is critical to function (Forger and Peskin,
2003).
Unlike most enzymatic reactions, which approximately double in
rate for each 101-temperature increase (Q10B2), circadian rhythms
are temperature compensated over the biological range (Q10B0.8–
1.4). For example, ﬁbroblasts cultured in vitro display a 26-h period
at 371C, but a 24-h period at 311C (Dibner et al, 2009). As many
cellular properties change markedly with temperature, the basis for
this aspect of the cellular oscillator’s robustness has remained
elusive (Akman et al, 2008).
Recently, several groups have reported observations that chal-
lenge the central hypothesis that ﬁne temporal control of transcrip-
tion levels lies at the heart of circadian timekeeping. For example,
constitutive over-expression of auto-repressors CRY1/2 does not
affect rhythmicity (Fan et al, 2007), whereas perturbations that
affect cyclic AMP signalling do so, dramatically (O’Neill et al, 2008).
Now, Dibner et al (2009) have shown clearly that the cellular
oscillator is remarkably resilient to large-scale changes in global
transcription. In this study, mouse ﬁbroblasts were pre-treated
with well-known transcriptional inhibitors a-amanitin and actino-
mycin D. Following treatment, a reduction of 470% in total
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Figure 1 Schematic showing the effect of transcriptional inhibition on the core transcriptional/translational feedback loop of the mammalian
circadian clock. Clock and Bmal1 transcription factors (red/black ovals) bind to E-box promoter elements, activating transcription of Period
(PER) and Cryptochrome (CRY) genes around subjective dawn. Following translation, PER/CRY are modiﬁed post-translationally (e.g., by
phosphorylation—green circles) before nuclear import, wherein they repress their own transcription. These inhibitory complexes are broken
down during subjective night. Ancillary loops (not shown) produce rhythmic expression of Bmal1. Pre-treatment of cells with transcriptional
inhibitors reduces global transcription rates, and has the effect of reducing the amplitude and period of clock gene expression (box).
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conﬁrmed that clock gene expression was similarly affected.
According to most of the circadian models tested, this should
have resulted in arrhythmicity or lengthened period, as indeed do
several other pharmacological effectors of the clock (Hastings et al,
2008).
Intriguingly, not only did the cultures in which transcription was
reduced remain rhythmic, albeit with lower amplitude, but also
inhibitor-treated cells ran signiﬁcantly faster, by 2–3h at 371C. This
effect was evident both at the whole culture and at the single-cell
level.
Most surprisingly, the period of inhibitor-treated cultures was
not as sensitive to changes in temperature as were control cultures
(Q10 closer to 1). Furthermore, ﬁbroblasts lacking the clock gene,
PER1, were less sensitive to transcriptional inhibition than controls,
and actually undercompensated for changes in temperature, result-
ing in shorter periods at higher temperatures.
These observations represent an advance in our understanding
of how the clockwork integrates with cellular function, but should
also facilitate enquiry into what additional mechanisms are respon-
sible for maintaining rhythmicity, even when the control of gene
expression has been impaired. It has been suggested earlier that
post-translational mechanisms such as phosphorylation (e.g. casein
kinase 1d/e and protein phosphatase 1 regulating PER2 degrada-
tion), and other cytosolic signalling processes, might have an
important function in this context (Hastings et al, 2008). This
paper will, therefore, further encourage a reappraisal of the con-
tributions that various molecular mechanisms make to sustain
cellular rhythms.
The authors also suggest that the processes underlying circadian
temperature compensation may be shared with those that buffer the
cell against the changes in gross transcriptional activity observed
between different tissues. The molecular characterisation of such a
mechanism would likely constitute a major challenge and a major
advance for cell biology research. Furthermore, the possibility that
PER1 constitutes a nexus between these two compensatory me-
chanisms serves to highlight the multi-functional roles of clock
genes, especially when considering that the PER genes have also
been implicated in tumour suppression (Lee, 2006).
Given that so many biological systems are under circadian
regulation, this work should have profound implications for re-
searchers in diverse ﬁelds. It is further hoped that these ﬁndings will
be extended to other tissues, such as the hypothalamic suprachias-
matic nuclei—the conserved master clock in mammals—so that we
can better understand how such compensatory mechanisms con-
tribute to physiological and metabolic homeostasis.
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